These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

758 related items for PubMed ID: 36737832

  • 1. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
    Hsiao SY, Weng SM, Hsiao JR, Wu YY, Wu JE, Tung CH, Shen WL, Sun SF, Huang WT, Lin CY, Chen SH, Hong TM, Chen YL, Chang JY.
    J Exp Clin Cancer Res; 2023 Feb 03; 42(1):40. PubMed ID: 36737832
    [Abstract] [Full Text] [Related]

  • 2. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
    Han L, Cheng J, Li A.
    Cancer Biother Radiopharm; 2021 Feb 03; 36(1):84-94. PubMed ID: 32302508
    [Abstract] [Full Text] [Related]

  • 3. miR-450b promotes cell migration and invasion by inhibiting SERPINB2 in oral squamous cell carcinoma.
    Wang X, Nie X, Xu G, Gao J, Wang B, Yang J, Song G.
    Oral Dis; 2024 Mar 03; 30(2):376-389. PubMed ID: 36251494
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O, Hasegawa S, Nagai H, Uchida F, Yamatoji M, Kanno NI, Yamagata K, Sakai S, Yanagawa T, Bukawa H.
    J Oral Pathol Med; 2016 Apr 03; 45(4):248-55. PubMed ID: 26307116
    [Abstract] [Full Text] [Related]

  • 5. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M, Wang C, Chen W, Mao C, Wang J.
    DNA Cell Biol; 2018 Apr 03; 37(4):381-388. PubMed ID: 29364705
    [Abstract] [Full Text] [Related]

  • 6. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
    He L, Guo J, Fan Z, Yang S, Zhang C, Cheng B, Xia J.
    Cell Signal; 2023 Jun 03; 106():110635. PubMed ID: 36813147
    [Abstract] [Full Text] [Related]

  • 7. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
    Wang F, Ye LJ, Wang FJ, Liu HF, Wang XL.
    Environ Toxicol; 2020 Oct 03; 35(10):1050-1057. PubMed ID: 32469461
    [Abstract] [Full Text] [Related]

  • 8. MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2.
    Wu M, Duan Q, Liu X, Zhang P, Fu Y, Zhang Z, Liu L, Cheng J, Jiang H.
    Biomed Pharmacother; 2020 Feb 03; 122():109696. PubMed ID: 31918270
    [Abstract] [Full Text] [Related]

  • 9. CircZDBF2 up-regulates RNF145 by ceRNA model and recruits CEBPB to accelerate oral squamous cell carcinoma progression via NFκB signaling pathway.
    Rong L, Chen B, Liu K, Liu B, He X, Liu J, Li J, He M, Zhu L, Liu K, Shi X, Shuai Y, Jin L.
    J Transl Med; 2022 Apr 01; 20(1):148. PubMed ID: 35365168
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-382-5p Promotes Oral Squamous Cell Carcinoma Development and Progression by Negatively Regulating PTEN Expression.
    Xu X, Jin B, Cai L, Zhang Z, Ying Y, Luo J.
    J Oral Maxillofac Surg; 2022 Dec 01; 80(12):2015-2023. PubMed ID: 36162436
    [Abstract] [Full Text] [Related]

  • 11. FOXN3 Expression Regulated by miR-299-5p Inhibiting the Proliferation, Migration and Invasion of Oral Squamous Cell Carcinoma Cells.
    Maimaitiming K, Yilihamu A, Keyimu K, Keranmu R, Li J, Xu H, Wufuer D.
    Protein Pept Lett; 2022 Dec 01; 29(9):788-795. PubMed ID: 35975858
    [Abstract] [Full Text] [Related]

  • 12. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression.
    Niu X, Yang B, Liu F, Fang Q.
    Biomed Pharmacother; 2020 Jan 01; 121():109623. PubMed ID: 31731187
    [Abstract] [Full Text] [Related]

  • 13. Effects of miR-9-5p on the migration, invasion and epithelial-mesenchymal transition process in cervical squamous cell carcinoma.
    Kuang T, Li L, Chen Y, Wang J.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jan 28; 48(1):15-23. PubMed ID: 36935173
    [Abstract] [Full Text] [Related]

  • 14. LINC00664/miR-411-5p/KLF9 feedback loop contributes to the human oral squamous cell carcinoma progression.
    Wang C, Wang Q, Weng Z.
    Oral Dis; 2023 Mar 28; 29(2):672-685. PubMed ID: 34582069
    [Abstract] [Full Text] [Related]

  • 15. MiR-32-5p promoted epithelial-to-mesenchymal transition of oral squamous cell carcinoma cells via regulating the KLF2/CXCR4 pathway.
    Qin SY, Li B, Chen M, Qin MQ, Liu JM, Lv QL.
    Kaohsiung J Med Sci; 2022 Feb 28; 38(2):120-128. PubMed ID: 34741382
    [Abstract] [Full Text] [Related]

  • 16. METTL3-Mediated Maturation of miR-99a-5p Promotes Cell Migration and Invasion in Oral Squamous Cell Carcinoma by Targeting ZBTB7A.
    Huang Y, Guan Y, Zhang X.
    Mol Biotechnol; 2024 Aug 28; 66(8):1942-1953. PubMed ID: 37498409
    [Abstract] [Full Text] [Related]

  • 17. Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data.
    Wang Y, Jiang Y, Chen L.
    J Cell Mol Med; 2020 Dec 28; 24(23):13824-13836. PubMed ID: 33107676
    [Abstract] [Full Text] [Related]

  • 18. LncRNA HOXD-AS1 promotes oral squamous cell carcinoma by sponging miR-203a-5p.
    Zhang Y, Wang F, Yu Y.
    Oral Dis; 2023 May 28; 29(4):1505-1512. PubMed ID: 35152529
    [Abstract] [Full Text] [Related]

  • 19. LncRNA DLEU1 facilitates the progression of oral squamous cell carcinoma by miR-126-5p/GAB1 axis.
    Sun KD, Ni YJ, Qin H, Xu QF.
    Kaohsiung J Med Sci; 2022 Oct 28; 38(10):950-959. PubMed ID: 36039933
    [Abstract] [Full Text] [Related]

  • 20. miR-30a-5p targets ITGA6 to inhibit oral squamous cell carcinoma progression.
    Zhang G, Wang H, Liu G, Huang J.
    Pathol Res Pract; 2024 Jan 28; 253():155021. PubMed ID: 38103366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.